BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction

Reuters

Jul 14

BRIEF-<a href="https://laohu8.com/S/EPIX">ESSA Pharma Inc.</a> Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction

July 14 (Reuters) - ESSA Pharma Inc EPIX.O:

ESSA PHARMA INC. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC., BACKED BY XOMA ROYALTY CORPORATION IN ALL-CASH TRANSACTION
ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CVR FOR UP TO $2.95 MILLION
ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CASH PAYMENT PER SHARE
ESSA PHARMA INC - SHAREHOLDERS ESTIMATED TO RECEIVE $1.91 PER SHARE
ESSA PHARMA INC - AGREEMENT INCLUDES $2.5 MILLION TERMINATION FEE

Source text: ID:nCNWS04TXa

Further company coverage: EPIX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2551186803"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551186803\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551186803?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-14 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551186803","market":"fut","top_or_hot":-1,"title":"BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EPIX\">ESSA Pharma Inc.</a> Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction</title></head><body><p><span>July 14 (Reuters)</span><span> - </span>ESSA Pharma Inc <span>EPIX.O</span>:</p><ul><li><p>ESSA PHARMA INC. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC., BACKED BY XOMA ROYALTY CORPORATION IN ALL-CASH TRANSACTION</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CVR FOR UP TO $2.95 MILLION</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CASH PAYMENT PER SHARE</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS ESTIMATED TO RECEIVE $1.91 PER SHARE</p></li><li><p>ESSA PHARMA INC - AGREEMENT INCLUDES $2.5 MILLION TERMINATION FEE</p></li></ul><p>Source text: <span>ID:nCNWS04TXa</span></p><p>Further company coverage: <span>EPIX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-14 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/EPIX\">ESSA Pharma Inc.</a> Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash Transaction</title></head><body><p><span>July 14 (Reuters)</span><span> - </span>ESSA Pharma Inc <span>EPIX.O</span>:</p><ul><li><p>ESSA PHARMA INC. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC., BACKED BY XOMA ROYALTY CORPORATION IN ALL-CASH TRANSACTION</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CVR FOR UP TO $2.95 MILLION</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CASH PAYMENT PER SHARE</p></li><li><p>ESSA PHARMA INC - SHAREHOLDERS ESTIMATED TO RECEIVE $1.91 PER SHARE</p></li><li><p>ESSA PHARMA INC - AGREEMENT INCLUDES $2.5 MILLION TERMINATION FEE</p></li></ul><p>Source text: <span>ID:nCNWS04TXa</span></p><p>Further company coverage: <span>EPIX.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EPIX","symbol_name":"ESSA Pharma Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nTUA3JPSD5:1","article_id":"2551186803","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551186803","pubTimestamp":1752494555,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash TransactionJuly 14 (Reuters) - ESSA Pharma Inc EPIX.O:ESS","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EPIX":"ESSA Pharma Inc.","XOMA":"标记临床研究","BK4139":"生物科技"},"translate_title":"简介-ESSA Pharma Inc.宣布最终协议将被Xenotherapeutics，Inc.收购，由XOMA Royalty Corporation以全现金交易支持","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EPIX":0.9,"XOMA":0.9},"content_text":"BRIEF-ESSA Pharma Inc. Announces Definitive Agreement To Be Acquired By Xenotherapeutics, Inc., Backed By XOMA Royalty Corporation In All-Cash TransactionJuly 14 (Reuters) - ESSA Pharma Inc EPIX.O:ESSA PHARMA INC. ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY XENOTHERAPEUTICS, INC., BACKED BY XOMA ROYALTY CORPORATION IN ALL-CASH TRANSACTIONESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CVR FOR UP TO $2.95 MILLIONESSA PHARMA INC - SHAREHOLDERS TO RECEIVE CASH PAYMENT PER SHAREESSA PHARMA INC - SHAREHOLDERS ESTIMATED TO RECEIVE $1.91 PER SHAREESSA PHARMA INC - AGREEMENT INCLUDES $2.5 MILLION TERMINATION FEESource text: ID:nCNWS04TXaFurther company coverage: EPIX.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}